FDA Approved: TERBUTALINE SULFATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for Terbutaline Sulfate from Amneal Pharmaceuticals of New York LLC, authorizing a modification to an existing product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Terbutaline sulfate (terbutaline sulfate)

Snippet

SUPPL AP for TERBUTALINE SULFATE (TERBUTALINE SULFATE)